Options Trading Available on Recently Launched Tradr ETFs: LABX, DOGD, MDBX and LRCU
Werte in diesem Artikel
Newly listed options deliver another trading tool to express high conviction views on growth stocks including Astera Labs and MongoDB
NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced that options trading is now available on its four newest leveraged ETFs: the Tradr 2X Long ALAB Daily ETF (Cboe: LABX), the Tradr 2X Long DDOG Daily ETF (Cboe: DOGD), the Tradr 2X Long MDB Daily ETF (Cboe: MDBX), and the Tradr 2X Long LRCX Daily ETF (Cboe: LRCU).
The four ETFs, all first-to-market products launched in August, allow traders to express their high conviction views on underlying stocks with strong ties to the AI data center boom: Astera Labs (Nasdaq: ALAB), Datadog (Nasdaq: DDOG), MongoDB (Nasdaq: MDB) and Lam Research (Nasdaq: LRCX).
"The launch of options trading on the four newest Tradr ETFs gives investors yet another tool to help navigate one of the most transformative investment themes of our time," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs.
For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.
About Tradr ETFs
Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.
IMPORTANT RISK INFORMATION
Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.
Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.
Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.
The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.
ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.
ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.
Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com. The Prospectus should be read carefully before investing.
Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000737
View original content to download multimedia:https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html
SOURCE Tradr ETFs
Übrigens: Datadog A und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Astera Labs
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Astera Labs
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Lam Research Corp.
Analysen zu Lam Research Corp.
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
29.10.2018 | Lam Research Neutral | B. Riley FBR |
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
17.10.2018 | Lam Research Outperform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
29.10.2018 | Lam Research Neutral | B. Riley FBR | |
01.10.2018 | Lam Research Hold | Deutsche Bank AG | |
01.10.2018 | Lam Research Neutral | Mizuho | |
12.10.2016 | Lam Research Sector Weight | Pacific Crest Securities Inc. | |
21.04.2015 | Lam Research Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
22.10.2015 | Lam Research Underperform | RBC Capital Markets | |
05.10.2015 | Lam Research Underperform | RBC Capital Markets | |
11.11.2010 | Lam Research sell | Citigroup Corp. | |
29.07.2010 | Lam Research sell | Citigroup Corp. | |
19.03.2009 | Lam Research underperform | Credit Suisse Group |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen